[Neuroendovascular therapy for acute stroke].
Ezura
Masayuki
M
Department of Neuroendovascular Therapy, Tohoku University, 2-1 Seiryo-cho, Aoba-ku, Sendai-City 980-8575, Japan.
Takahashi
Akira
A
Matsumoto
Yasushi
Y
D015906:Angioplasty, Balloon, Coronary; D002404:Catheterization; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D015552:Injections, Intralesional; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000008:administration & dosage; D015607:Stents; D020521:Stroke / Q000628:therapy*; D015912:Thrombolytic Therapy; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator; C067551:saruplase